Matrix Metalloproteinase-9?: Many Shades of Function in Cardiovascular Disease.

Author(s): Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML

Abstract

Matrix metalloproteinase (MMP)-9, one of the most widely investigated MMPs, regulates pathological remodeling processes that involve inflammation and fibrosis in cardiovascular disease. MMP-9 directly degrades extracellular matrix (ECM) proteins and activates cytokines and chemokines to regulate tissue remodeling. MMP-9 deletion or inhibition has proven overall beneficial in multiple animal models of cardiovascular disease. As such, MMP-9 expression and activity is a common end point measured. MMP-9 cell-specific overexpression, however, has also proven beneficial and highlights the fact that little information is available on the underlying mechanisms of MMP-9 function. In this review, we summarize our current understanding of MMP-9 physiology, including structure, regulation, activation, and downstream effects of increased MMP-9. We discuss MMP-9 roles during inflammation and fibrosis in cardiovascular disease. By concentrating on the substrates of MMP-9 and their roles in cardiovascular disease, we explore the overall function and discuss future directions on the translational potential of MMP-9 based therapies.

Similar Articles

Global Atlas on Cardiovascular Disease Prevention and Control.

Author(s): Mendis S, Puska P, Norrving B

Pathogenesis of Acute Coronary Syndromes

Author(s): Crea F, Liuzzo G

Mechanisms of Plaque Formation and Rupture

Author(s): Bentzon JF, Otsuka F, Virmani R, Falk E

Association of serum MMP-9 with autoantibodies against oxidized LDL

Author(s): Kalela A, Koivu TA, Höyhtyä M, Jaakkola O, Lehtimäki T

2013 ESC guidelines on the management of stable coronary artery disease: Eur Heart

Author(s): Montalescot G, Sechtem U, Achenbach S, Andreotti F

Chronic Stable Angina.

Author(s): Abrams J

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

Author(s): Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A

The oxidation ratio of LDL: a predictor for coronary artery disease.

Author(s): Huang H, Mai W, Liu D, Hao Y, Tao J

Antibodies against oxLDL and acute coronary syndrome.

Author(s): Medeiros AM, von Mühlen CA, Gidlund MA, Bodanese R, Gottlieb MG

Plaque regression and plaque stabilisation in cardiovascular diseases.

Author(s): Dave T, Ezhilan J, Vasnawala H, Somani V

Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease

Author(s): Kalela A, Koivu TA, Sisto T, Kanervisto J, Höyhtyä M